Novartis + Microsoft reimagining medicine using AI

In the world of commercial research and science, there’s probably no undertaking more daunting—or more expensive—than the process of bringing a new medicine to market. For a new compound to make it from initial discovery through development, testing, and clinical trials to finally earn regulatory approval can take a decade or more.  Learn how Novartis and Microsoft are coming together using AI and leading research capabilities to advance medicine.

Follow us on social: